Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis

[1]  Youfeng Shen,et al.  Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database , 2022, Journal of oncology.

[2]  N. Le,et al.  Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation , 2022, Functional & Integrative Genomics.

[3]  Xueying Han,et al.  Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC , 2022, Open medicine.

[4]  Truc-Vien T. Nguyen,et al.  Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis , 2021, Biomedicines.

[5]  Fangfang Li,et al.  Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma , 2021, Frontiers in Endocrinology.

[6]  Shuai Wu,et al.  Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo , 2021, Disease markers.

[7]  Yan Gao,et al.  NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis , 2021, Frontiers in Immunology.

[8]  S. Okada,et al.  Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma , 2021, PeerJ.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  Zhiping Tan,et al.  Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis , 2021, Technology in cancer research & treatment.

[11]  Caicun Zhou,et al.  Lung cancer in China: current and prospect , 2020, Current opinion in oncology.

[12]  Riken Chen,et al.  Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis , 2020, Translational cancer research.

[13]  Z. Fasoulakis,et al.  Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review , 2020, AntiCancer Research.

[14]  Haosheng Jin,et al.  CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[15]  Xiyong Wang,et al.  miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2 , 2020, OncoTargets and therapy.

[16]  Jingnan Shen,et al.  CDC20 and its downstream genes: potential prognosis factors of osteosarcoma , 2019, International Journal of Clinical Oncology.

[17]  C. Lian,et al.  CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β-catenin signaling pathway , 2019, International journal of oncology.

[18]  Qing-Yu He,et al.  A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma. , 2018, Cancer letters.

[19]  Yuan Gao,et al.  Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells. , 2018, Oncology reports.

[20]  Hong Yang,et al.  Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma , 2017, Oncology letters.

[21]  K. Hardwick,et al.  Generation of a Spindle Checkpoint Arrest from Synthetic Signaling Assemblies , 2017, Current Biology.

[22]  Xin Gao,et al.  Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel. , 2016, International journal of oncology.

[23]  Ju-Han Lee,et al.  MAD2 and CDC20 are Upregulated in High-grade Squamous Intraepithelial Lesions and Squamous Cell Carcinomas of the Uterine Cervix , 2014, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[24]  A. Masoudi-Nejad,et al.  Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma , 2013, PloS one.

[25]  P. Hwu,et al.  Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression , 2012, Journal of Hematology & Oncology.

[26]  I. Bar,et al.  Usefulness of CDK5RAP3, CCNB2, and RAGE Genes for the Diagnosis of Lung Adenocarcinoma , 2007 .

[27]  J. Sandbank,et al.  Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. , 2007, The International journal of biological markers.

[28]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[29]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[30]  K. Engeland,et al.  The tumour suppressor protein p53 can repress transcription of cyclin B. , 2000, Nucleic acids research.

[31]  Rong Li,et al.  Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis. , 2019, Archives of medical research.

[32]  A. Jemal,et al.  Lung Cancer Statistics. , 2016, Advances in experimental medicine and biology.